ArticleAmerican journal of preventive cardiology2026
Small, dense LDL-C as a predictor of cardiovascular risk and benefit of alirocumab in patients with recent acute coronary syndrome receiving optimized statin treatment.
Gregory G Schwartz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.